108 related articles for article (PubMed ID: 34675917)
1. Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.
Li W; Tanikawa T; Kryczek I; Xia H; Li G; Wu K; Wei S; Zhao L; Vatan L; Wen B; Shu P; Sun D; Kleer C; Wicha M; Sabel M; Tao K; Wang G; Zou W
Cell Metab; 2018 Jul; 28(1):87-103.e6. PubMed ID: 29805099
[TBL] [Abstract][Full Text] [Related]
2. Knock down of APE1 suppressed gastric cancer metastasis via improving immune disorders caused by myeloid-derived suppressor cells.
Zhang B; Tang Q; Shi W; Bao Z; Gao S; Pan C
Cell Cycle; 2024 Mar; 23(5):602-612. PubMed ID: 38717991
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment.
Pilatova K; Bencsikova B; Demlova R; Valik D; Zdrazilova-Dubska L
Cancer Immunol Immunother; 2018 Dec; 67(12):1919-1929. PubMed ID: 29748897
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide N -methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma.
Li Y; Yang B; Miao H; Liu L; Wang Z; Jiang C; Yang Y; Qiu S; Li X; Geng Y; Zhang Y; Liu Y
Hepatology; 2023 Nov; 78(5):1352-1367. PubMed ID: 36633260
[TBL] [Abstract][Full Text] [Related]
5. Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.
Ramirez CFA; Taranto D; Ando-Kuri M; de Groot MHP; Tsouri E; Huang Z; de Groot D; Kluin RJC; Kloosterman DJ; Verheij J; Xu J; Vegna S; Akkari L
Nat Commun; 2024 Mar; 15(1):2581. PubMed ID: 38519484
[TBL] [Abstract][Full Text] [Related]
6. A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation.
Kerr SC; Morgan MM; Gillette AA; Livingston MK; Lugo-Cintron KM; Favreau PF; Florek L; Johnson BP; Lang JM; Skala MC; Beebe DJ
Integr Biol (Camb); 2020 Oct; 12(10):250-262. PubMed ID: 33034643
[TBL] [Abstract][Full Text] [Related]
7. The dominant-negative mitochondrial calcium uniporter subunit MCUb drives macrophage polarization during skeletal muscle regeneration.
Feno S; Munari F; Reane DV; Gissi R; Hoang DH; Castegna A; Chazaud B; Viola A; Rizzuto R; Raffaello A
Sci Signal; 2021 Nov; 14(707):eabf3838. PubMed ID: 34726954
[TBL] [Abstract][Full Text] [Related]
8. Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions.
Chaib M; Tanveer UA; Makowski L
Pharmacol Ther; 2023 Apr; 244():108370. PubMed ID: 36871784
[TBL] [Abstract][Full Text] [Related]
9. PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer.
Gjerstorff MF; Traynor S; Gammelgaard OL; Johansen S; Pedersen CB; Ditzel HJ; Terp MG
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551639
[TBL] [Abstract][Full Text] [Related]
10. The paradoxical role of MDSCs in inflammatory bowel diseases: From bench to bedside.
Zhao F; Gong W; Song J; Shen Z; Cui D
Front Immunol; 2022; 13():1021634. PubMed ID: 36189262
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy.
De Sanctis F; Adamo A; Canè S; Ugel S
Semin Immunopathol; 2023 Mar; 45(2):163-186. PubMed ID: 36161514
[TBL] [Abstract][Full Text] [Related]
12. G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors.
He K; Liu X; Hoffman RD; Shi RZ; Lv GY; Gao JL
FEBS Open Bio; 2022 Jul; 12(7):1268-1285. PubMed ID: 35612789
[TBL] [Abstract][Full Text] [Related]
13. MDSCs and T cells in solid tumors and non-Hodgkin lymphomas: an immunosuppressive speech.
Cioccarelli C; Molon B
Clin Exp Immunol; 2022 Jun; 208(2):147-157. PubMed ID: 35348617
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF Nitration Is a New Driver of Myeloid Suppressor Cell Activity in Tumors.
Calì B; Agnellini AHR; Cioccarelli C; Sanchez-Rodriguez R; Predonzani A; Toffolo GI; Viola A; Bronte V; Arrigoni G; Zonta F; Albertoni L; Mescoli C; Marigo I; Molon B
Front Immunol; 2021; 12():718098. PubMed ID: 34675917
[TBL] [Abstract][Full Text] [Related]
15. Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF.
Sun HW; Wu WC; Chen HT; Xu YT; Yang YY; Chen J; Yu XJ; Wang Z; Shuang ZY; Zheng L
Front Immunol; 2020; 11():616367. PubMed ID: 33603745
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients.
Khanna S; Graef S; Mussai F; Thomas A; Wali N; Yenidunya BG; Yuan C; Morrow B; Zhang J; Korangy F; Greten TF; Steinberg SM; Stetler-Stevenson M; Middleton G; De Santo C; Hassan R
Clin Cancer Res; 2018 Jun; 24(12):2859-2872. PubMed ID: 29602801
[No Abstract] [Full Text] [Related]
17. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
Front Immunol; 2019; 10():183. PubMed ID: 30863394
[TBL] [Abstract][Full Text] [Related]
18. Mutualistic Effects of the Myeloid-Derived Suppressor Cells and Cancer Stem Cells in the Tumor Microenvironment.
Tanriover G; Aytac G
Crit Rev Oncog; 2019; 24(1):61-67. PubMed ID: 31679221
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
